Rolley E. Johnson

6.4k total citations · 1 hit paper
79 papers, 5.1k citations indexed

About

Rolley E. Johnson is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Rolley E. Johnson has authored 79 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Public Health, Environmental and Occupational Health, 25 papers in Pediatrics, Perinatology and Child Health and 18 papers in Epidemiology. Recurrent topics in Rolley E. Johnson's work include Opioid Use Disorder Treatment (48 papers), Prenatal Substance Exposure Effects (22 papers) and Substance Abuse Treatment and Outcomes (16 papers). Rolley E. Johnson is often cited by papers focused on Opioid Use Disorder Treatment (48 papers), Prenatal Substance Exposure Effects (22 papers) and Substance Abuse Treatment and Outcomes (16 papers). Rolley E. Johnson collaborates with scholars based in United States, Bulgaria and Spain. Rolley E. Johnson's co-authors include Paul J. Fudala, George E. Bigelow, Donald R. Jasinski, Maxine L. Stitzer, Eric C. Strain, Hendrée E. Jones, Ira A. Liebson, Sharon Walsh, Edward J. Cone and Mary Ann Chutuape and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Rolley E. Johnson

79 papers receiving 4.7k citations

Hit Papers

A Comparison of Levometha... 2000 2026 2008 2017 2000 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Rolley E. Johnson 3.1k 1.5k 1.3k 1.0k 851 79 5.1k
Richard S. Schottenfeld 3.4k 1.1× 3.4k 2.2× 1.1k 0.9× 1.1k 1.1× 350 0.4× 153 6.4k
Elinore F. McCance‐Katz 2.2k 0.7× 2.1k 1.4× 1.2k 0.9× 963 1.0× 358 0.4× 116 5.6k
Andrew J. Saxon 2.6k 0.8× 2.7k 1.7× 777 0.6× 890 0.9× 312 0.4× 222 6.2k
Ira A. Liebson 1.9k 0.6× 1.7k 1.1× 463 0.3× 932 0.9× 782 0.9× 118 4.9k
Eric C. Strain 4.1k 1.3× 2.9k 1.9× 1.0k 0.8× 2.2k 2.1× 854 1.0× 199 8.7k
Jerome H. Jaffe 1.9k 0.6× 2.1k 1.4× 729 0.5× 839 0.8× 1.2k 1.4× 166 6.0k
Paul J. Fudala 1.7k 0.5× 1.0k 0.7× 461 0.3× 543 0.5× 591 0.7× 60 3.0k
Donald R. Jasinski 2.0k 0.6× 1000 0.6× 752 0.6× 1.5k 1.5× 1.7k 1.9× 106 7.0k
Gary Kenneth Hulse 1.6k 0.5× 1.4k 0.9× 1.3k 1.0× 989 1.0× 563 0.7× 194 5.1k
Maria A. Sullivan 1.6k 0.5× 1.2k 0.8× 450 0.3× 939 0.9× 250 0.3× 99 3.5k

Countries citing papers authored by Rolley E. Johnson

Since Specialization
Citations

This map shows the geographic impact of Rolley E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolley E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolley E. Johnson more than expected).

Fields of papers citing papers by Rolley E. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolley E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolley E. Johnson. The network helps show where Rolley E. Johnson may publish in the future.

Co-authorship network of co-authors of Rolley E. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Rolley E. Johnson. A scholar is included among the top collaborators of Rolley E. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolley E. Johnson. Rolley E. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Himes, Sarah K., Robert S. Goodwin, Hendrée E. Jones, et al.. (2012). Methadone and Metabolites in Hair of Methadone-Assisted Pregnant Women and Their Infants. Therapeutic Drug Monitoring. 34(3). 337–344. 14 indexed citations
2.
Concheiro, Marta, Hendrée E. Jones, Rolley E. Johnson, Robin E. Choo, & Marilyn A. Huestis. (2011). Preliminary Buprenorphine Sublingual Tablet Pharmacokinetic Data in Plasma, Oral Fluid, and Sweat During Treatment of Opioid-Dependent Pregnant Women. Therapeutic Drug Monitoring. 33(5). 619–626. 40 indexed citations
3.
Barnes, Allan J., Bertrand Brunet, Robin E. Choo, et al.. (2010). Excretion of Methadone in Sweat of Pregnant Women Throughout Gestation After Controlled Methadone Administration. Therapeutic Drug Monitoring. 32(4). 497–503. 9 indexed citations
4.
Concheiro, Marta, Hendrée E. Jones, Rolley E. Johnson, Diaá M. Shakleya, & Marilyn A. Huestis. (2009). Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women. Journal of Chromatography B. 878(1). 13–20. 23 indexed citations
5.
Jones, Hendrée E., Kevin E. O’Grady, Jennifer Dahne, et al.. (2009). Management of Acute Postpartum Pain in Patients Maintained on Methadone or Buprenorphine During Pregnancy. The American Journal of Drug and Alcohol Abuse. 35(3). 151–156. 53 indexed citations
7.
Jones, Hendrée E., Patricia E. Suess, Donald R. Jasinski, & Rolley E. Johnson. (2006). Transferring Methadone‐Stabilized Pregnant Patients to Buprenorphine Using an Immediate Release Morphine Transition: An Open‐Label Exploratory Study. American Journal on Addictions. 15(1). 61–70. 17 indexed citations
8.
Fudala, Paul J. & Rolley E. Johnson. (2006). Development of opioid formulations with limited diversion and abuse potential. Drug and Alcohol Dependence. 83. S40–S47. 45 indexed citations
9.
Marsch, Lisa A., et al.. (2005). Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.. Experimental and Clinical Psychopharmacology. 13(4). 293–302. 61 indexed citations
10.
Jones, Hendrée E., Rolley E. Johnson, Donald R. Jasinski, et al.. (2005). Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug and Alcohol Dependence. 79(1). 1–10. 238 indexed citations
11.
Johnson, Rolley E., Hendrée E. Jones, Donald R. Jasinski, et al.. (2001). Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug and Alcohol Dependence. 63(1). 97–103. 98 indexed citations
12.
Strain, Eric C., et al.. (2001). Gradual Dose Taper Following Chronic Buprenorphine. American Journal on Addictions. 10(2). 111–121. 20 indexed citations
13.
Johnson, Rolley E., et al.. (2000). Buprenorphine and Naloxone for Heroin Dependence. Current Psychiatry Reports. 2(6). 519–526. 47 indexed citations
14.
Eissenberg, Thomas, Rolley E. Johnson, George E. Bigelow, et al.. (1997). Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients. Drug and Alcohol Dependence. 45(1-2). 81–91. 29 indexed citations
15.
Montoya, Iván D., et al.. (1995). Estudio comparativo de la psicopatología y de las funciones cognitivas en pacientes dependientes de la cocaína y los opiáceos. 19–24. 1 indexed citations
16.
Johnson, Rolley E., Thomas Eissenberg, Maxine L. Stitzer, et al.. (1995). A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence. 40(1). 17–25. 161 indexed citations
17.
Brooke, Deborah, Paul J. Fudala, & Rolley E. Johnson. (1992). Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA. Drug and Alcohol Dependence. 31(1). 37–43. 18 indexed citations
18.
Fudala, Paul J., et al.. (1991). Use of naloxone in the assessment of opiate dependence. Life Sciences. 49(24). 1809–1814. 8 indexed citations
19.
Bickel, Warren K., Maxine L. Stitzer, George E. Bigelow, et al.. (1988). Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 47–53. 190 indexed citations
20.
Kumor, Karen M., Charles A. Haertzen, Donald R. Jasinski, & Rolley E. Johnson. (1988). The psychopharmacologic and prolactin response after large doses of naloxone in man. Pharmacology Biochemistry and Behavior. 30(4). 967–975. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026